2022 JPAD Article

/in , , , , /by

2022 Journal of Prevention of Alzheimer’s Disease:

 

ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aβ Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan

2022 Frontiers in Neuroscience

/in , , , , /by

2022 Frontiers in Neuroscience:

 

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease